Differential Kinase Activation in Peripheral Blood Mononuclear Cells from Non-Small-Cell Lung Cancer Patients Treated with Nivolumab

In the era of precision medicine, research of biomarkers for identification of responders to nivolumab therapy is a major challenge. Peripheral blood mononuclear cells (PBMC) could be an interesting surrogate tissue for identifying pharmacodynamic biomarkers. The aim of this exploratory study was to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Noé, Gaëlle, Bellesoeur, Audrey, Golmard, Lisa, Thomas-Schoemann, Audrey, Boudou-Rouquette, Pascaline, Tiako Meyo, Manuela, Puszkiel, Alicja, Arrondeau, Jennifer, Alexandre, Jérome, Goldwasser, François, Blanchet, Benoit, Vidal, Michel
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6628172/
https://ncbi.nlm.nih.gov/pubmed/31159331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11060762
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados